Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: Relationships with chronological and ovarian age

Author： Palomba Stefano   Falbo Angela   Orio Francesco   Russo Tiziana   Sbano Francesco   D'alessandro Pietro   Cariati Francesco   Tolino Achille   Colao Annamaria   Zullo Fulvio  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.22, Iss.6, 2006-06, pp. : 329-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?

By Palomba Stefano  

Human Reproduction, Vol. 19, Iss. 11, 2004-11 ,pp. : 2682-2683

Oxford University Press

Access to resources Recommend Favorite

Reply to: Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?

By van Wely Madelon  

Human Reproduction, Vol. 19, Iss. 11, 2004-11 ,pp. : 2683-2683

Oxford University Press

Access to resources Recommend Favorite

Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome

By Amer S.A.   Li T.C.   Metwally M.   Emarh M.   Ledger W.L.  

Human Reproduction, Vol. 24, Iss. 1, 2009-01 ,pp. : 219-225

Oxford University Press

Access to resources Recommend Favorite

An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome

By van Wely M.  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1741-1745

Oxford University Press

Access to resources Recommend Favorite

Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women's health-related quality of life

By van Wely M.  

Human Reproduction, Vol. 19, Iss. 10, 2004-10 ,pp. : 2244-2250

Oxford University Press

Access to resources Recommend Favorite